FDA Approves OXYCODONE AND ACETAMINOPHEN — KVK-Tech, Inc.
KVK-Tech, Inc. has secured FDA approval for its ANDA211499 to manufacture and market an authorized generic version of oxycodone and acetaminophen, signaling an increase in competition for this widely used analgesic brand. This move is expected to drive down pricing in the market by offering a more affordable alternative to the branded product.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed